DOPAMINE-RECEPTORS IN THE BASAL GANGLIA - RELEVANCE TO PARKINSONS-DISEASE

被引：70
|
作者：
STRANGE, PG
机构：
[1] Biological Laboratory, The University, Canterbury, Kent
来源：
MOVEMENT DISORDERS | 1993年 / 8卷 / 03期
关键词：
DOPAMINE RECEPTORS; PARKINSONS DISEASE; DRUG TREATMENT; NEOSTRIATUM; MOTOR CONTROL;
D O I：
10.1002/mds.870080303
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
At least five receptors for dopamine (D1-D5) have been recognised from molecular biological studies, and their pharmacological properties and brain localisations have been determined. The D1 and D2 subtypes are the principal subtypes in brain, and their cellular localisations in the caudate nucleus and putamen have been determined. With recent advances in the understanding of basal ganglia neuronal function, these localisation data enable insights into the mode of action of drugs used at present and in the future to treat Parkinson's disease.
引用
收藏
页码：263 / 270
页数：8
相关论文
共 50 条
  • [31] DOPAMINE AGONISTS IN PARKINSONS-DISEASE
    DUBOIS, B
    AGID, Y
    REVUE DU PRATICIEN, 1986, 36 (05): : 207 - 214
  • [32] MET-ENKEPHALIN IMMUNOREACTIVITY IN THE BASAL GANGLIA IN PARKINSONS-DISEASE AND STRIATONIGRAL DEGENERATION
    GOTO, S
    HIRANO, A
    MATSUMOTO, S
    NEUROLOGY, 1990, 40 (07) : 1051 - 1056
  • [33] DOPAMINE, TREMOR, AND PARKINSONS-DISEASE
    HIRSCH, EC
    MOUATT, A
    FAUCHEUX, B
    BONNET, AM
    JAVOYAGID, F
    GRAYBIEL, AM
    AGID, Y
    LANCET, 1992, 340 (8811): : 125 - 126
  • [34] AKINESIA AND DISSOCIATED MOTOR INVOLVEMENT DUE TO PARKINSONS-DISEASE AND BASAL GANGLIA LESIONS
    RONDOT, P
    REVUE NEUROLOGIQUE, 1990, 146 (10) : 591 - 599
  • [35] COGNITION AND THE BASAL GANGLIA - SEPARATING MENTAL AND MOTOR COMPONENTS OF PERFORMANCE IN PARKINSONS-DISEASE
    RAFAL, RD
    POSNER, MI
    WALKER, JA
    FRIEDRICH, FJ
    BRAIN, 1984, 107 (DEC) : 1083 - 1094
  • [36] DOPAMINE AGONISTS IN PARKINSONS-DISEASE
    CALNE, DB
    BURTON, K
    BECKMAN, J
    MARTIN, WRW
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (01) : 221 - 224
  • [37] DOPAMINE AGONISTS AND PARKINSONS-DISEASE
    BURTON, K
    CALNE, DB
    CLINICAL NEUROLOGY AND NEUROSURGERY, 1984, 86 (03) : 172 - 177
  • [38] PARKINSONS-DISEASE WITH INVOLVEMENT OF THE PARASYMPATHETIC GANGLIA
    TAKEDA, S
    YAMAZAKI, K
    MIYAKAWA, T
    ARAI, H
    ACTA NEUROPATHOLOGICA, 1993, 86 (04) : 397 - 398
  • [39] PARKINSONS-DISEASE, DOPAMINE, AND PERSONALITY
    MENZA, M
    FORMAN, NE
    GOLDSTEIN, HE
    GOLBE, LI
    ANNALS OF NEUROLOGY, 1989, 26 (01) : 125 - 125
  • [40] PRIMATE MODEL OF PARKINSONS-DISEASE - ALTERATIONS IN MULTIPLE OPIOID SYSTEMS IN THE BASAL GANGLIA
    ZAMIR, N
    SKOFITSCH, G
    BANNON, MJ
    HELKE, CJ
    KOPIN, IJ
    JACOBOWITZ, DM
    BRAIN RESEARCH, 1984, 322 (02) : 356 - 360
12345